42
Participants
Start Date
November 30, 2006
Primary Completion Date
September 30, 2008
Study Completion Date
October 31, 2008
MEDI-563
"BIW-8405/MEDI-563 administered at one of five dose levels:~* 0.03 mg/kg intravenous injection~* 0.1 mg/kg intravenous injection~* 0.3 mg/kg intravenous injection~* 1.0 mg/kg intravenous injection~* 3.0 mg/kg intravenous injection~Following the -3.0 mg/kg dose level,~BIW-8405/MEDI-563 administered at one of two lower dose levels:~0.003 mg/kg intravenous injection 0.0003 mg/kg intravenous injection"
Allergy-Asthma-K4, Madison
Jewish Medical and Research Center, Denver
Northeast Medical Research Associates, Inc., North Darthmouth
Lead Sponsor
MedImmune LLC
INDUSTRY